Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.53 USD | -2.79% | -2.16% | -30.99% |
May. 13 | Transcript : Zevra Therapeutics, Inc. - Shareholder/Analyst Call | |
May. 08 | Earnings Flash (ZVRA) ZEVRA THERAPEUTICS Reports Q1 Revenue $3.4M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-30.99% | 195M | |
+16.34% | 79.03B | |
+8.65% | 8.78B | |
-16.33% | 4.83B | |
+51.22% | 4.65B | |
+2.18% | 3.89B | |
+20.51% | 2.34B | |
-26.79% | 2.18B | |
+15.12% | 2.11B | |
-36.56% | 2B |
- Stock Market
- Equities
- ZVRA Stock
- News Zevra Therapeutics, Inc.
- Canaccord Genuity Adjusts Price Target on Zevra Therapeutics to $20 From $19, Keeps Buy Rating